Gregory M Sullivan

3PUBLICATIONS
7CO-AUTHORS
Molecular targetsPainMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Apr 29, 2026
First-in-Human, Phase 1, Randomized, Double-Blind, Placebo-Controlled Study of TNX-1500, an Fc-Modified anti-CD154 Monoclonal Antibody, Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single-Ascending Doses in Healthy Adults.

|Jul 08, 2025
Pain relief by targeting nonrestorative sleep in fibromyalgia: a phase 3 randomized trial of bedtime sublingual cyclobenzaprine.

Seth Lederman, Lesley M Arnold, Ben Vaughn

|May 11, 2023
Efficacy and Safety of Sublingual Cyclobenzaprine for the Treatment of Fibromyalgia: Results From a Randomized, Double-Blind, Placebo-Controlled Trial.

Seth Lederman, Lesley M Arnold, Ben Vaughn

Pageof 1

Frequent Collaborators

2 joint publications

Seth Lederman

1 joint publications

Lesley M Arnold

1 joint publications

Ben Vaughn

1 joint publications

Jean M Engels